WHC is still in active development. Read this to understand our approach.
depiction of LYONXVJRBWWGQO-UHFFFAOYSA-N.svg
tripsit

carphedon

Verificar en tripsit

psychonaut

Phenylpiracetam

Verificar en psychonaut

isomerdesign

Phenylpiracetam

Verificar en isomerdesign

druglab

Phénylpiracétam

Verificar en druglab

wiki

Phenylpiracetam

Verificar en wiki

Data

InChI: InChI=1S/C12H14N2O2/c13-11(15)8-14-7-10(6-12(14)16)9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,13,15)

Sinónimos: 2-Oxo-4-phenyl-1-pyrrolidineacetamide,2-(2-Oxo-4-phenyl-pyrrolidin-1-yl)-acetamide,HMS3886K15,2-(2-oxo-4-phenyl-pyrrolidin-1-yl)acetamide,1-Pyrrolidineacetamide, 2-oxo-4-phenyl-, (4S)-,J-500892,Oprea1_429090,SDCCGMLS-0035015.P002,AMY38209,2-(2-keto-4-phenyl-pyrrolidin-1-yl)acetamide,4-Phenylpiracetam; Carphedon,DB-075328,2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide,4-PHENYLPIRACETAM [WHO-DD],472P709,2-(2-oxo-4-phenyl-1-pyrrolidinyl)acetamide,Phenotropil,CCG-266708,MLS000113218,HY-14840,phenotropil,A839108,BRN 5030440,4-Phenyl-2-oxopyrrolidine-1-acetamide,AKOS000519394,Carphedon,F11808,4-Phenyl-2-pyrrolidone-1-acetamide,UNII-99QW5JU66Y,DS-1993,HMS2183I11,P2604,PHENOTROPYL,BBL100068,BCP22034,EX-A735,Fonturacetam,MFCD01456750,SMR000109123,DTXSID30868438,(R,S)-2-(2-OXO-4-PHENYLPYRROLIDIN-1-YL)ACETAMIDE,Q420882,(2-Oxo-4-phenylpyrrolidin-1-yl)acetamide,SB17150,CS-1574,Carphedone,FONTURACETAM [MART.],AKOS016038810,Carphedo,s5223,2-(2-oxidanylidene-4-phenyl-pyrrolidin-1-yl)ethanamide,1-Pyrrolidineacetamide, 2-oxo-4-phenyl-,STL511045,F2147-9813,Fonturacetam [INN],SCHEMBL563022,Phenylpiracetam,99QW5JU66Y,CHEMBL348639,(RS)-2-(2-Oxo-4-phenylpyrrolidin-1-y1) acetamide,RAC-2-((4R)-2-OXO-4-PHENYLPYROLIDIN-1-YL)ACETAMIDE,phenypiracetam,Oprea1_208829,2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide;Phenylpiracetam,77472-70-9,4-Phenylpiracetam,Karfedon,phenylpiracetam

Estimated data

Solubilidad: -1.58 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 60.6% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.